Polymorphisms in the Paraoxonase and Endothelial Nitric Oxide Synthase Genes and the Risk of Early-Onset Myocardial Infarction

American Journal of Cardiology

Volumn 99, Issue 8, 2007, Pages 1100-1105

  Morray, Brian ^a   Goldenberg, Ilan ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a   Ryan, Daniel ^a   McNitt, Scott ^a   Eberly, Shirley W ^a   Glazko, Galina ^a   Mathew, Jehu ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARGININE; ARYLDIALKYLPHOSPHATASE; ASPARTIC ACID; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34147191727     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.022     Document Type: Article

References (27)

1. ten Kate L.P., Boman H., Daiger S.P., and Motulsky A.G. Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Am J Cardiol 50 (1982) 945-953
2. Myers R.H., Kiely D.K., Cupples L.A., and Kannel W.B. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 120 (1990) 963-969
3. Hamsten A., and de Faire U. Risk factors for coronary artery disease in families of young men with myocardial infarction. Am J Cardiol 59 (1987) 14-19
4. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., and Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
5. McCarthy J.J., Parker A., Salem R., Moliterno D.J., Wang Q., Plow E.F., Rao S., Shen G., Rogers W.J., Newby L.K., et al., GeneQuest Investigators. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 41 (2004) 334-341
6. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
7. Boekholdt S.M., Bijsterveld N.R., Moons A.H., Levi M., Buller H.R., and Peters R.J. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104 (2001) 3063-3068
8. Hauser E.R., Crossman D.C., Granger C.B., Haines J.L., Jones C.J., Mooser V., McAdam B., Winkelmann B.R., Wiseman A.H., Muhlestein J.B., et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 75 (2004) 436-447
9. Moss A.J., Goldstein R.E., Marder V.J., Sparks C.E., Oakes D., Greenberg H., Weiss H.J., Zareba W., Brown M.W., Liang C.S., et al. Thrombogenic factors and recurrent coronary events. Circulation 99 (1999) 2517-2522
10. Moss A.J., Ryan D., Oakes D., Goldstein R.E., Greenberg H., Bodenheimer M.M., Brown M.W., Case R.B., Dwyer Jr. E.M., Eberly S.W., et al. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. Am J Cardiol 96 (2005) 177-182
11. Senti M., Tomas M., Vila J., Marrugat J., Elosua R., Sala J., and Masia R. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR Study. Atherosclerosis 156 (2001) 443-449
12. Mackness M.I., Arrol S., and Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286 (1991) 152-154
13. Mackness B., Mackness M.I., Arrol S., Turkie W., and Durrington P.N. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 122 (1997) 265-268
14. Mackness B., Mackness M.I., Arrol S., Turkie W., and Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423 (1998) 57-60
15. Ruiz J., Blanche H., James R.W., Garin M.C., Vaisse C., Charpentier G., Cohen N., Morabia A., Passa P., and Froguel P. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346 (1995) 869-872
16. Pfohl M., Koch M., Enderle M.D., Kuhn R., Fullhase J., Karsch K.R., and Haring H.U. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 48 (1999) 623-627
17. Wheeler J.G., Keavney B.D., Watkins H., Collins R., and Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363 (2004) 689-695
18. Serrato M., and Marian A.J. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 96 (1995) 3005-3008
19. Suehiro T., Nakauchi Y., Yamamoto M., Arii K., Itoh H., Hamashige N., and Hashimoto K. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int J Cardiol 57 (1996) 69-73
20. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., and Webb R.C. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78 (1996) 225-230
21. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2 (1987) 1057-1058
22. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88 (1991) 4651-4655
23. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., and Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103 (1998) 65-69
24. Yoon Y., Song J., Hong S.H., and Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46 (2000) 1626-1630
25. Moon J., Yoon S., Kim E., Shin C., Jo S.A., and Jo I. Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb Res 107 (2002) 129-134
26. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., Haydock S., Hopper R.V., Stephens N.G., O'Shaughnessy K.M., and Brown M.J. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
27. Casas J.P., Bautista L.E., Humphries S.E., and Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109 (2004) 1359-1365